mobile menu icon

Bristows LLP & CIPA event: IP rights panel discussion

27/01/2014

GO

Sign up for events

If you would like to subscribe to Bristows’ Events & seminar invitations, please sign up below.

Events Calendar
Type
Date
Is the treatment of IP rights in European Commission competition cases harming innovation?
 

Over the past year, the Competition Directorate of the European Commission has been carrying out a number of investigations which directly involve intellectual property rights.
 
Both the pharmaceutical sector, where patent settlements and related agreements have been under scrutiny, and the TMT sector, where the seeking of injunctions for standard essential patents has been questioned, are in the spotlight. Each of those industries has debated these issues, but there has been less cross-industry debate on the consequences of the Commission’s cases more broadly.
 
CIPA, together with Bristows LLP will be hosting a high profile panel discussion about the current treatment of IP, and in particular patents, in the competition cases of the European Commission. At its heart, this panel discussion is designed for the patent and IP community and will be chaired by Michael Silverleaf QC, 11 South Square and will include speakers who have been selected from among leading Judges, Professors, regulators and industry experts:
  • Henri Piffaut, Head of Unit, Pharma & Health Services, DG Competition
  • Bo Vesterdorf, former President of the European Court of First Instance
  • Alison Brimelow, former President of the European Patent Office
  • Ian S. Forrester QC, LLD, Partner, White & Case
  • Philip Strassburger, Vice President, General Counsel, Purdue Pharma L.P. (USA)
Key issues that will be covered
  • Are DG Competition’s cases in different sectors consistent with each other in their treatment of IP rights?
  • Could the cases have unintended consequences in terms of effects for other sectors?
  • Are impediments to the enforcement of IP rights being created by competition law and what are the consequences for investment and innovation?
  • What are the concerns around the possible prohibition of technology acquisitions and licence grants?
  • Does the IP community need to change its approach to the settlement of litigation?
  • How do these cases fit with the introduction of the UPC?
  • The international perspective – how will these issues affect Europe’s competitiveness, and what are other parts of the world doing differently?
Schedule

4:30pm - Registration and refreshments
5:00pm - Panel discussion to begin
7:00pm - Close of panel discussion followed by a drinks reception in the lounge
27/01/2014
16:30
Bristows Seminar
Bristows LLP, 100 Victoria Embankment, London EC4Y 0DH

Share to: 
Unknown